The more I look into this, the better it gets Agent.
Imo, everything appears to be lining up towards another Twiggy "FMG" success story.
Firstly, I doubt he's poured millions of his own personal wealth into this out of the kindness of his heart.
Secondly, he's placed the inaugural CFO of Fortescue, Mr Catlow at the helm of his ship, as Chairman of the board. Recently retired Executive Director of FMG, Mr Rowley who played a central role in the development of Fortescue from its inception is appointed to the Board as a non-executive director.
Bell Potter investment advisor and director of Avexa Ltd (Avexa also a major s/holding in BioMD), Mr Soedirdja, given the other non-executive directors seat
Ex-Director and Vice president of a U.S. based Healthcare Consulting & Distribution Company specializing on GE Healthcare products and services, Mr Rodne of course is MD
Two highly respected scientists with 2006 Australian of the Year and best known as the developer of the Gardasil cervical cancer vaccine, Prof Frazer is focused on developing next generation DNA vaccines for a range of infectious diseases and Cancer, and Prof Neethling, the developer of unique tissue engineering technologies.
"BioMD is commercialising innovative tissue engineering technology for use in cardiovascular and soft tissue repair surgery. The technology offers significant improvements to current tissue processing technologies in terms of immunogenicity and tissue durability. Its lead product, CardioCel, has been evaluated in a Phase II human trial in South Africa for various cardiac repair procedures. bioMD is currently maximising shareholder value via pursuit of corporate partnerships, successful completion of clinical milestones and rapid commercialisation strategies."
Allied Medical is an Australian based company that is emerging as a major healthcare commercialisation player focused on growing its profitable distribution business providing medical devices and technology to healthcare professionals and building its major interest in Coridon Pty Ltd, developing DNA vaccines for global markets.
Allied Medical's established distribution business consists of innovative and cost effective medical devices and technologies with applications across a broad scope of medical specialties including anaesthesiology, critical care, pain management, infectious diseases, emergency medicine and cardiology. __________
The world's ageing population and a huge focus on the future of global healthcare is one of the trends some of the world's largest investors are looking at now.
Perhaps this is also Mr Forrests motivation, I'm happy to believe so anyway.
The average global life expectancy at birth is now 70, compared with 65 in 1990. The UN has also estimated that there were 455,000 people in the world aged over 100 in 2009, up from 110,000 in 1990.
Further, I've been finding through my research of the biotech sector over the last 2 years that over stretched resources within our professional health systems will force a significant move of hospital care towards homecare and this is where new technologies will be in huge demand.
The following presentation I found last year is definitely worth sparing some time to listen to or read the transcript if you're interested in biotech stocks and like me believe we are entering a golden era of the biotech boom.
Surprisingly, this was a telecommunications conference held in Auckland, NZ and presented by Dr Hugh Bradlow, Chief Technology Officer of Telstra. Skip to the part where he addresses the link to the health industry if you can't spare time for the full presentation: __________
"Healthcare is another area which is going to be dramatically changed, so we've already been experimenting with remote consultations, you have a trolley like the one in the middle here that goes to the patients bedsides. You have a paramedic who is operating the trolley, but the details of the patient, their bio signs and their video in high definition is going back to the hospital at base, and the physician there is actually directing the patient care.
Now the other big thing that'll happen is as we have a aging population, keeping people - letting them - age gracefully in their own homes is going to become increasingly important, and there are a couple of things that will happen there. The one is the homes themselves will become smarter, and know about people in the home and be able to detect things like whether a person has fallen or not. But the individuals themselves will be much more carefully monitored, so you can think of things like bio sensors measuring blood glucose, blood oxygen, blood pressure, heart rate. Those things are all coming into play as we speak, and increasingly being able to do what were previously invasive measurements like blood sugar monitoring, being able to do that non-invasively and automatically.
So you can have a person fully instrumented in a very convenient fashion. Their mobile phone is a relay station and being able to send that information through to a monitoring system in the hospital which will look for anomalies or changes in conditions, and then set an alarm which will bring in a medical carer who will be able to determine whether that requires intervention or not. There are also things like automated reminders. I've seen the most amazing system where they can actually tell whether a patient has taken their pills or not. The pill actually has a RFID in it which is powered by your stomach acid, and will send out a signal to a transducer that sits on your chest, and will then relay that via your phone to the hospital, and it will be able to tell whether you're actually on your medication.
Now for a number of medical mental illnesses that's a critical factor, because patients feel better and stop taking their pills and of course then go into decline. This system will enable that sort of treatment to be determined automatically. Then from the point of view of doctors, being able to give them better data about their patients, and also about the state of the art of medical health. So today routinely, my brother who's a physician will put up, when he's examining a patient will put up their previous X-rays and he can look at a whole X-ray history of a particular aspect of rheumatology which he's studying.
Click HERE to read or listen to the full presentation - well worth the time imo
BOD Price at posting:
6.9¢ Sentiment: LT Buy Disclosure: Held
(20min delay)
